Literature DB >> 6205359

Analysis of the variations in proviral cytosine methylation that accompany transformation and morphological reversion in a line of Rous sarcoma virus-infected Rat-1 cells.

S Searle, D A Gillespie, D J Chiswell, J A Wyke.   

Abstract

Cells of the A11 lineage of Rat-1 contain a single complete Rous sarcoma provirus. Variation in the activity of this provirus accompanies fluctuations in the lineage between normal and transformed phenotypes. Increased proviral cytosine methylation of the doublet CpG in the tetranucleotide CCGG correlates with transcriptional inactivity and this pattern of cytosine hypermethylation is stable, even when the cells are transformed by another virus. However, transformation can also be induced by 5-azacytidine (but not by other mutagens) and in these transformants reduced proviral cytosine methylation is accompanied by increased proviral transcription. Differences in CCGG methylation between normal and transformed cells are found mainly in the 3' half of the provirus; sites near and within the src gene are heavily methylated only when the provirus is transcriptionally inactive. On the other hand, both transformed and normal A11 derivatives show little, if any, cytosine methylation of CCGG sequences in and flanking the 5' portion of the provirus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205359      PMCID: PMC318913          DOI: 10.1093/nar/12.13.5193

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation.

Authors:  M Groudine; R Eisenman; H Weintraub
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

2.  Developmental activation of the H-2K gene is correlated with an increase in DNA methylation.

Authors:  K Tanaka; E Appella; G Jay
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

3.  Expression of the ASV src gene in hybrids between normal and virally transformed cells: specific suppression occurs in some hybrids but not others.

Authors:  P J Dyson; K Quade; J A Wyke
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

4.  Molecular mechanisms involved in morphological variation of avian sarcoma virus-infected rat cells.

Authors:  D J Chiswell; P J Enrietto; S Evans; K Quade; J A Wyke
Journal:  Virology       Date:  1982-01-30       Impact factor: 3.616

5.  Infection of rat cells by avian sarcoma virus: factors affecting transformation and subsequent reversion.

Authors:  J A Wyke; K Quade
Journal:  Virology       Date:  1980-10-30       Impact factor: 3.616

6.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

7.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

8.  The changes in proviral chromatin that accompany morphological variation in avian sarcoma virus-infected rat cells.

Authors:  D J Chiswell; D A Gillespie; J A Wyke
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

9.  Infectivity and methylation of retroviral genomes is correlated with expression in the animal.

Authors:  H Stuhlmann; D Jähner; R Jaenisch
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

10.  Active viral genes in transformed cells lie close to the nuclear cage.

Authors:  P R Cook; J Lang; A Hayday; L Lania; M Fried; D J Chiswell; J A Wyke
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  11 in total

1.  DNA methylation and transcriptional controls of proviral DNA in avian sarcoma virus-transformed mammalian cells.

Authors:  F Catala
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

2.  CpG island protects Rous sarcoma virus-derived vectors integrated into nonpermissive cells from DNA methylation and transcriptional suppression.

Authors:  J Hejnar; P Hájková; J Plachy; D Elleder; V Stepanets; J Svoboda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  Variable stability of a selectable provirus after retroviral vector gene transfer into human cells.

Authors:  D J Jolly; R C Willis; T Friedmann
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

4.  Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx.

Authors:  Natalia Shalginskikh; Andrey Poleshko; Anna Marie Skalka; Richard A Katz
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

5.  The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing.

Authors:  Filip Senigl; Jirí Plachý; Jirí Hejnar
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

6.  The chromatin structure of Rous sarcoma proviruses is changed by factors that act in trans in cell hybrids.

Authors:  P J Dyson; P R Cook; S Searle; J A Wyke
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

7.  Transcriptional provirus silencing as a crosstalk of de novo DNA methylation and epigenomic features at the integration site.

Authors:  Filip Senigl; Miroslav Auxt; Jirí Hejnar
Journal:  Nucleic Acids Res       Date:  2012-02-29       Impact factor: 16.971

8.  DNA methylation and differentiation.

Authors:  L A Michalowsky; P A Jones
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

Review 9.  Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.

Authors:  Julia D Suerth; Verena Labenski; Axel Schambach
Journal:  Viruses       Date:  2014-12-05       Impact factor: 5.048

10.  Accumulation of long-term transcriptionally active integrated retroviral vectors in active promoters and enhancers.

Authors:  Filip Šenigl; Dalibor Miklík; Miroslav Auxt; Jirí Hejnar
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.